China's Former Drug Registration Chief Gets Suspended Death Sentence (China)
This article was originally published in PharmAsia News
Former State Food and Drug Administration drug registration chief Cao Wenzhuang received a suspended death sentence for seeking "benefits" from two pharmaceutical companies in exchange for approving their drug and medical equipment applications. He will serve seven years in prison, lose all property he possesses, and his sentence of death includes a two-year reprieve. He led the division from 2003 to 2005. (Click here for more
You may also be interested in...
This month’s column covers deals announced between 1-23 April 2020.
Celltrion’s Truxima has become the first rituximab biosimilar, and just the second biosimilar overall, to be prequalified by the WHO.
EU MDR Panel Discussion: Why An Extra Year Is Not Really A Delay For The MDR – How To Survive Changing And Confusing Times
26 May 2020, the date that the Medical Device Regulation was originally due to apply in the EU, was a good time to take stock of where the medtech sector finds itself. Three of the most renowned and outspoken experts on the EU medical device regulatory system gave their views in this exclusive interview.